US Patent Issued to Astellas Institute for Regenerative Medicine on June 16 for "Methods for production of platelets from pluripotent stem cells and compositions thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. RE50,916, issued on June 16, was assigned to Astellas Institute for Regenerative Medicine (Westborough, Mass.).

"Methods for production of platelets from pluripotent stem cells and compositions thereof" was invented by Qiang Feng (Natick, Mass.), Shi-Jiang Lu (Shrewsbury, Mass.) and Robert P. Lanza (Clinton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for production of platelets from pluripotent stem cells, such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are provided. These methods may be performed without forming embryoid bodies or clusters of pluripotent stem cells, and may be performed without the u...